# Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform

> **NCT04868500** · NA · COMPLETED · sponsor: **AstraZeneca** · enrollment: 49 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** AMAZE™ Application
- **DEVICE:** AMAZE™ Dashboard

## Key facts

- **NCT ID:** NCT04868500
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-27
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868500, "Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04868500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*